Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Breast Cancer

Free Subscription Articles published in Cancer Epidemiol Biomarkers Prev Retrieve available abstracts of 83 articles: HTML format

Single Articles

September 2025
1. WANG X, Yang X, Chen R, Liu W, et al
   Aspirin Use and Risk of Breast Cancer Recurrence in Chinese Patients.
   Cancer Epidemiol Biomarkers Prev. 2025.
   PubMed     Abstract available
   
   
   
2. CHEN JH, Slack Tidwell RS, Kai M, Lucci A, et al
   Impact of Postpartum Diagnosis on Survival of Women with Inflammatory Breast Cancer.
   Cancer Epidemiol Biomarkers Prev. 2025.
   PubMed     Abstract available
   
   
   
3. KIM EY, Shin S, Chang Y, Ryu S, et al
   Serum Ferritin and Iron-Related Biomarkers in Relation to Breast Cancer Risk by Menopausal Status: A Prospective Cohort Study.
   Cancer Epidemiol Biomarkers Prev. 2025 Sep 8. doi: 10.1158/1055-9965.EPI-25-0923
   PubMed     Abstract available
   
   
   
4. CHOI HL, Jung W, Youn J, Kim B, et al
   Risk of Parkinson's Disease Among Breast Cancer Survivors: A Nationwide Cohort Study in South Korea.
   Cancer Epidemiol Biomarkers Prev. 2025 Sep 4. doi: 10.1158/1055-9965.EPI-25-0712
   PubMed     Abstract available
   
   
   August 2025
5. ABDOLLAHPOUR I, Darouei B, Amani-Beni R, Yazdi M, et al
   Lifetime Sunlight Exposure and Risk of Breast Cancer: A Population-based incident Case-Control Study.
   Cancer Epidemiol Biomarkers Prev. 2025.
   PubMed     Abstract available
   
   
   
6. DONZELLA SM, Rogers M, O'Brien KM, Von Holle A, et al
   Sedentary time and breast cancer risk in the Sister Study Cohort.
   Cancer Epidemiol Biomarkers Prev. 2025.
   PubMed     Abstract available
   
   
   
7. TELONIS AG, Hernandez AE, Borowsky PA, Reguero Hernandez ED, et al
   Molecular Portraits of Social Adversity in Breast Cancer: Neighborhood Disadvantage is Associated with Epigenetic Deregulation of Key Oncogenic Pathways.
   Cancer Epidemiol Biomarkers Prev. 2025.
   PubMed     Abstract available
   
   
   
8. BOROWSKY PA, Nahodyl L, Sable S, Sierra MA, et al
   Residential Proximity to NPL Superfund Sites and High Particulate Matter Exposure is Associated with Increased Likelihood of Triple Negative Breast Cancer.
   Cancer Epidemiol Biomarkers Prev. 2025.
   PubMed     Abstract available
   
   
   
9. LOEHRER EA, van der Baan FH, Mooij TM, Andrieu N, et al
   Breast Density Changes after Risk-Reducing Salpingo-oophorectomy in Women with a Pathogenic Germline Variant in BRCA1 or BRCA2.
   Cancer Epidemiol Biomarkers Prev. 2025;34:1295-1305.
   PubMed     Abstract available
   
   
   
10. YAGHJYAN L, Tamimi RM, Baker GM, Heng YJ, et al
    Associations of Stem Cell Markers with Lobular Involution in Benign Breast Tissue.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1314-1321.
    PubMed     Abstract available
    
    
    
11. CARROLL JE, Guard HE, March D, Arcaro KF, et al
    Urinary Levels of Endocrine-Disrupting Chemicals and Breast Density in Young Women.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1306-1313.
    PubMed     Abstract available
    
    
    July 2025
12. ALVAREZ SOTO A, Gan W, Tannenbaum S
    Racial Disparities in Pathologic Complete Response and Survival after Neoadjuvant Chemotherapy for Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
13. FOWLER ME, Reeves HD, Smith MJ, Saini G, et al
    Structural determinants of racial disparities in breast cancer survival in Alabama.
    Cancer Epidemiol Biomarkers Prev. 2025 Jul 9. doi: 10.1158/1055-9965.EPI-25-0195
    PubMed     Abstract available
    
    
    
14. NAIR NM, Mendicino L, Fiorica PN, Omilian AR, et al
    The African-specific variant in the Duffy Antigen Receptor for Chemokines (DARC) gene, CD8+ T-cell density and Aggressive Breast Cancer Subtypes in Black Women.
    Cancer Epidemiol Biomarkers Prev. 2025 Jul 8. doi: 10.1158/1055-9965.EPI-25-0454
    PubMed     Abstract available
    
    
    
15. LAMBERT PC, Andersson TML, Myklebust TA, Moller B, et al
    Monitoring Temporal Trends in Cancer Survival: Choosing Appropriate Standards When Accounting for Age and Other-Cause Mortality Variation Over Time.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1141-1148.
    PubMed     Abstract available
    
    
    June 2025
16. TAUB CJ, Hernandez AE, Borowsky PA, Ream M, et al
    Distinct Sources of Social Adversity, Stress, and Coping Mechanisms Among Breast Cancer Patients to Identify Areas for Intervention.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
17. FRITSCH-HUMBLET B, Jiao Y, Eon-Marchais S, Dondon MG, et al
    Body mass index, IGF1-related polymorphisms and risk of familial breast cancer in women with no BRCA1 or BRCA2 pathogenic variant.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
18. READING JM, Solk P, Starikovsky J, Song J, et al
    Effects of a Physical Activity mHealth Intervention (Fit2Thrive) on WCRF/AICR Cancer Prevention Score among Breast Cancer Survivors: A Secondary Data Analysis.
    Cancer Epidemiol Biomarkers Prev. 2025 Jun 9. doi: 10.1158/1055-9965.EPI-25-0167
    PubMed     Abstract available
    
    
    
19. MCTIERNAN A
    Lifestyle and Breast Cancer Risk: How Does It All Add Up?
    Cancer Epidemiol Biomarkers Prev. 2025;34:833-835.
    PubMed     Abstract available
    
    
    
20. FENLON J, Van Bibber N, Mahlow J, Yamoah K, et al
    Human Immunodeficiency Virus-Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers.
    Cancer Epidemiol Biomarkers Prev. 2025;34:860-867.
    PubMed     Abstract available
    
    
    
21. KELLY RL, Liu Y, Harris AR, Peng C, et al
    The Breast Tumor Immune Microenvironment of DNA Double-Strand Break Repair Pathogenic Variant Carriers Is Enriched with Tumor-Associated Macrophages.
    Cancer Epidemiol Biomarkers Prev. 2025;34:868-874.
    PubMed     Abstract available
    
    
    May 2025
22. WILSON OW, Matthews CE, Wojcik KM, Tarasenko YN, et al
    The Effects of Post-Diagnosis Recreational Aerobic Exercise among Breast Cancer Survivors: A Systematic Review/Meta-Analyses.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
23. AOKI RL, Alexeeff SE, Caan BJ, Kushi LH, et al
    Nativity and Healthy Lifestyle Index in a Pooled Cohort of Female Breast Cancer Survivors from Northern California.
    Cancer Epidemiol Biomarkers Prev. 2025 May 7. doi: 10.1158/1055-9965.EPI-24-1871
    PubMed     Abstract available
    
    
    April 2025
24. DUNN MR, Niu H, Li D, Emerson MA, et al
    Applying a novel measure of community-level healthcare access to assess breast cancer care timeliness.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
25. BERGIN ART, Te Marvelde L, Milne RL, Lara Gonzalez LE, et al
    Aboriginal and Torres Strait Islander females and survival from breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
26. TANG L, Wang Z, Hsiao HH, Kwan ML, et al
    Associations of Cruciferous Vegetable Intake with Breast Cancer Survival in a Diverse Population in the Pathways Study.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
27. ROHAN TE, Zhang C, Wang Y, Couch FJ, et al
    p16, COX-2, and Ki67 protein expression in DCIS and risk of ipsilateral invasive breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
28. VERDIESEN RMG, Shokouhi M, Burgess S, Canisius S, et al
    Causal effects of breast cancer risk factors across hormone receptor breast cancer subtypes: A two-sample Mendelian randomization study.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
29. LIMA SM, Palermo TM, Lee FF, Insaf TZ, et al
    Historical redlining and all-cause survival after breast cancer diagnosis.
    Cancer Epidemiol Biomarkers Prev. 2025 Apr 3. doi: 10.1158/1055-9965.EPI-24-1862
    PubMed     Abstract available
    
    
    
30. QIN B, Vyas M, Moore SC, Su X, et al
    Reproducibility of Plasma Metabolome Over 1 Year in a Population-based Cohort of Black Breast Cancer Survivors.
    Cancer Epidemiol Biomarkers Prev. 2025 Apr 3. doi: 10.1158/1055-9965.EPI-24-1646
    PubMed     Abstract available
    
    
    
31. MCDONALD JA
    Unveiling the Stroma: Reproductive Factors and the Tumor Microenvironment in African Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2025;34:459-461.
    PubMed     Abstract available
    
    
    March 2025
32. OGBENNA BT, He X, Wu AH, Le Marchand L, et al
    Healthy Lifestyle Index and Breast Cancer Risk among Postmenopausal Women: The Multiethnic Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
33. DAVIS S, Lian M, Colditz GA, Davis KL, et al
    Racialized Economic Segregation, Treatment and Outcomes in Women with Triple-Negative Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
34. REN Y, Maselko J, Tan X, Olshan AF, et al
    PATTERNS OF CHANGE IN EMOTIONAL AND FUNCTIONAL WELL-BEING FOLLOWING BREAST CANCER DIAGNOSIS.
    Cancer Epidemiol Biomarkers Prev. 2025 Mar 4. doi: 10.1158/1055-9965.EPI-24-0849
    PubMed     Abstract available
    
    
    
35. ALBERS FEM, Dashti SG, Lynch BM
    Epidemiologic Studies of Biomarkers and Their Role in Carcinogenesis: The Need for a Formal Causal Inference Approach.
    Cancer Epidemiol Biomarkers Prev. 2025;34:373-374.
    PubMed     Abstract available
    
    
    February 2025
36. PLASCAK JJ, Xing CY, Mooney SJ, Rundle AG, et al
    Neighborhood disinvestment predicts shorter cancer survival time among Black women diagnosed with invasive breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
37. SCHROTH W, Murdter TE, Schwab M
    Unraveling the Impact of Drug Metabolism on Tamoxifen Response in Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2025;34:221-223.
    PubMed     Abstract available
    
    
    January 2025
38. WALKER B, Pollard E, Howard SP, Jones VM, et al
    The Role of Race/Ethnicity on the Association between Neighborhood Deprivation and Breast Cancer Outcomes among Kentucky Breast Cancer Patients years 2010-2022.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
39. HERNANDEZ AE, Borowsky PA, Nahodyl L, Pinheiro PS, et al
    A Neighborhood-Level Hispanic Paradox: the Interaction between Hispanic Density, Neighborhood Disadvantage, and Survival in Breast Cancer Patients.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
40. ALBERS FE, Swain CT, Lou MW, Dashti SG, et al
    Insulin and insulin-like growth factor and risk of postmenopausal estrogen receptor-positive breast cancer: a case-cohort analysis.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
41. MAVADDAT N, Ficorella L, Carver T, Lee A, et al
    Correction: Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model.
    Cancer Epidemiol Biomarkers Prev. 2025;34:205.
    PubMed    
    
    
    
42. ANAMPA JD, Lin S, Obeng-Gyasi S, Xue X, et al
    Treatment and Survival Differences between Patients with Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma of the Breast.
    Cancer Epidemiol Biomarkers Prev. 2025;34:125-132.
    PubMed     Abstract available
    
    
    December 2024
43. HUANG X, Lott PC, Hu D, Zavala VA, et al
    Evaluation of multiple breast cancer polygenic risk score panels in women of Latin American heritage.
    Cancer Epidemiol Biomarkers Prev. 2024 Dec 3. doi: 10.1158/1055-9965.EPI-24-1247
    PubMed     Abstract available
    
    
    
44. POURALI G, Toriola AT
    The Untapped Opportunities of Addressing Lifecourse Growth in Mammographic Breast Density and Breast Cancer Prevention in Non-Hispanic Black Women.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1541-1543.
    PubMed     Abstract available
    
    
    
45. NABI O, Liu Y, Struthers J, Lian M, et al
    The Role of Residential Segregation in Treatment and Outcomes of Ductal Carcinoma In Situ of the Breast.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1633-1639.
    PubMed     Abstract available
    
    
    
46. BIGHAM Z, Holder EX, Rodday AM, Breeze JL, et al
    Lifecourse Growth and Development Determinants of Mammographic Density in Black Women.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1640-1650.
    PubMed     Abstract available
    
    
    November 2024
47. DENG Z, Visvanathan K
    Patterns of subsequent cancer incidence over time in patients with breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
48. MACLEHOSE RF, Ahern TP, Collin LJ, Li A, et al
    CYP2D6 Phenotype and Breast Cancer Outcomes: A Bias Analysis and Meta-Analysis.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
49. KOKA H, Tian Y, Deng L, Yu K, et al
    Mammographic density in relation to breast cancer risk factors among Chinese women.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
50. LORONA NC, Othus M, Malone KE, Linden HM, et al
    Metabolic syndrome and risks of breast cancer outcomes for luminal, triple-negative, and HER2-overexpressing subtypes.
    Cancer Epidemiol Biomarkers Prev. 2024 Nov 1. doi: 10.1158/1055-9965.EPI-24-1167
    PubMed     Abstract available
    
    
    
51. CURRO II, Teasdale CA, Wyatt LC, Foster V, et al
    Cancer Screening, Knowledge, and Fatalism among Chinese, Korean, and South Asian Residents of New York City.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1475-1483.
    PubMed     Abstract available
    
    
    October 2024
52. KEHM RD, Genkinger JM, Knight JA, Maclnnis RJ, et al
    Physical activity during adolescence and early adulthood and breast cancer risk before age 40 years.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
53. ASHAD-BISHOP KC, Star J, Giaquinto AN, Smith RA, et al
    Changes in Breast Cancer Screening Prevalence in the US During the COVID-19 Pandemic, 2018-2022.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
54. SARMIENTO DD, Tumas N, Pereyra SA, Scruzzi GF, et al
    Social determinants of breast cancer screening: a multilevel analysis of proximal and distal factors related to the practice of mammography.
    Cancer Epidemiol Biomarkers Prev. 2024 Oct 3. doi: 10.1158/1055-9965.EPI-24-1001
    PubMed     Abstract available
    
    
    
55. MARCUS POST L, Pathak DR, Hamilton AS, Hirko KA, et al
    Adiposity throughout Adulthood and Risk of Young Onset Breast Cancer Tumor Subtypes in the Young Women's Health History Study.
    Cancer Epidemiol Biomarkers Prev. 2024 Oct 2. doi: 10.1158/1055-9965.EPI-24-1067
    PubMed     Abstract available
    
    
    
56. WOOF VG, Howell A, Fox L, McWilliams L, et al
    Are women's breast cancer risk appraisals in line with updated clinical risk estimates communicated? Results from a UK Family History Risk and Prevention Clinic.
    Cancer Epidemiol Biomarkers Prev. 2024 Oct 2. doi: 10.1158/1055-9965.EPI-24-0581
    PubMed     Abstract available
    
    
    
57. ARANDA-GUTIERREZ A, Soto-Perez-de-Celis E
    The Disconnect between Clinical Guidelines and Reality: The Case of Trastuzumab.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1259-1260.
    PubMed     Abstract available
    
    
    
58. ABE JV, Legaspi J, Guillermo C, Bogumil D, et al
    Breast, Colorectal, and Prostate Cancer Incidence among Filipino Americans by Generational Status in the Multiethnic Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1311-1317.
    PubMed     Abstract available
    
    
    September 2024
59. WOJCIK KM, Wilson OWA, Shiels MS, Sheppard VL, et al
    Racial, Ethnic, and Socioeconomic Disparities in Meeting Physical Activity Guidelines among Female Breast Cancer Survivors in the United States.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
60. KALIA SS, Boddicker NJ, Yadav S, Huang H, et al
    Development of a breast cancer risk prediction model integrating monogenic, polygenic, and epidemiologic risk.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    August 2024
61. BRANTLEY KD, Ziegler RG, Craft NE, Hankinson SE, et al
    Circulating Estrogen Metabolites and Risk of Breast Cancer among Postmenopausal Women in the Nurses' Health Study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
62. PARK GE, Kim SH, Han K
    A Large Cohort Study of Height and Mammographic Density in Relation to Breast Cancer Risk among Korean Women.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
63. SINGH RK, Getz KR, Kyeyune JK, Jeon MS, et al
    Aspirin Metabolites and Mammographic Breast Density in Premenopausal Women.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1126-1128.
    PubMed     Abstract available
    
    
    July 2024
64. BHIMANI J, O'Connell K, Persaud S, Blinder V, et al
    Patient characteristics associated with intended non-guideline chemotherapy in women with stage I-IIIA breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
65. ANG BH, Teo SH, Ho WK
    Systematic review and meta-analysis of lifestyle and reproductive factors associated with risk of breast cancer in Asian women.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
66. NORRIS RP, Dew R, Greystoke A, Cresti N, et al
    Socio-demographic disparities in HER2+ breast cancer trastuzumab receipt: An English population-based study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
67. ABUBAKAR M, Ahearn TU, Duggan MA, Lawrence S, et al
    Contribution of pre-diagnostic host factors to shaping the stromal microenvironment of breast cancer among sub-Saharan African women.
    Cancer Epidemiol Biomarkers Prev. 2024 Jul 3. doi: 10.1158/1055-9965.EPI-24-0390
    PubMed     Abstract available
    
    
    
68. OH H, Yaghjyan L, Heng YJ, Rosner B, et al
    Associations of Early-Life and Adult Anthropometric Measures with the Expression of Stem Cell Markers CD44, CD24, and ALDH1A1 in Women with Benign Breast Biopsies.
    Cancer Epidemiol Biomarkers Prev. 2024;33:933-943.
    PubMed     Abstract available
    
    
    June 2024
69. LOHANI KR, Nibbe AM, Vierkant RA, Pacheco-Spann LM, et al
    Understanding benign breast disease and subsequent breast cancer in Hispanic white females; a step closer to evidence-based management.
    Cancer Epidemiol Biomarkers Prev. 2024 Jun 5. doi: 10.1158/1055-9965.EPI-24-0204
    PubMed     Abstract available
    
    
    
70. YAGHJYAN L, Wang Z, Warner ET, Rosner B, et al
    Reproductive Factors Related to Childbearing and a Novel Automated Mammographic Measure, V.
    Cancer Epidemiol Biomarkers Prev. 2024;33:804-811.
    PubMed     Abstract available
    
    
    May 2024
71. YE Z, Nguyen TL, Dite GS, Maclnnis RJ, et al
    Mammographic texture versus conventional Cumulus measure of density in breast cancer risk prediction: a literature review.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
72. FREEMAN JQ, Huo D
    Addressing Social Determinants in the Era of Precision Medicine in Breast Cancer: Is It Sufficient to Reduce Disparities?
    Cancer Epidemiol Biomarkers Prev. 2024;33:635-637.
    PubMed     Abstract available
    
    
    
73. JATOI I
    Breast Cancer Screening: Can We Justify Deescalation?
    Cancer Epidemiol Biomarkers Prev. 2024;33:638-640.
    PubMed     Abstract available
    
    
    
74. PARK JE, Smith MA, Van Alsten SC, Walens A, et al
    Diffsig: Associating Risk Factors with Mutational Signatures.
    Cancer Epidemiol Biomarkers Prev. 2024;33:721-730.
    PubMed     Abstract available
    
    
    
75. VAN ALSTEN SC, Dunn MR, Hamilton AM, Ivory JM, et al
    Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status.
    Cancer Epidemiol Biomarkers Prev. 2024;33:654-661.
    PubMed     Abstract available
    
    
    April 2024
76. PARADA H, Wu T, Hoh E, Rock CL, et al
    Red Blood Cell Polyunsaturated Fatty Acids and Mortality Following Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
77. COLLISTER JA, Liu X, Littlejohns TJ, Cuzick J, et al
    Assessing the value of incorporating a polygenic risk score with non-genetic factors for predicting breast cancer diagnosis in the UK Biobank.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
78. MOSS JL, Geyer NR, Lengerich EJ
    Patterns of Cancer-Related Healthcare Access across Pennsylvania: Analysis of Novel Census Tract-Level Indicators of Persistent Poverty.
    Cancer Epidemiol Biomarkers Prev. 2024;33:616-623.
    PubMed     Abstract available
    
    
    
79. BARBER LE, McCullough LE, Johnson DA
    Eyes Wide Open: Sleep as a Potential Contributor to Racial and Ethnic Disparities in Cancer.
    Cancer Epidemiol Biomarkers Prev. 2024;33:471-479.
    PubMed     Abstract available
    
    
    
80. HAN E, Van Horn L, Snetselaar L, Shepherd JA, et al
    The Associations between Intakes of One-Carbon Metabolism-Related Vitamins and Breast Density among Young Women.
    Cancer Epidemiol Biomarkers Prev. 2024;33:567-575.
    PubMed     Abstract available
    
    
    March 2024
81. SIEGEL SD, Zhang Y, Lynch SM, Rowland J, et al
    A Novel Approach for Conducting a Catchment Area Analysis of Breast Cancer by Age and Stage for a Community Cancer Center.
    Cancer Epidemiol Biomarkers Prev. 2024 Mar 7. doi: 10.1158/1055-9965.EPI-23-1125
    PubMed     Abstract available
    
    
    
82. LEE M, Kotake R, Yamauchi H
    Physical Activity and Mammographic Density in Japanese Women.
    Cancer Epidemiol Biomarkers Prev. 2024;33:365-370.
    PubMed     Abstract available
    
    
    February 2024
83. FARBER R, Houssami N, McGeechan K, Barratt A, et al
    Breast cancer stage and size detected with film versus digital mammography in New South Wales, Australia: a population-based study using routinely collected data.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.